These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
409 related articles for article (PubMed ID: 35886945)
41. The concept of bio-corona in modulating the toxicity of engineered nanomaterials (ENM). Westmeier D; Stauber RH; Docter D Toxicol Appl Pharmacol; 2016 May; 299():53-7. PubMed ID: 26592323 [TBL] [Abstract][Full Text] [Related]
42. Updates on Biogenic Metallic and Metal Oxide Nanoparticles: Therapy, Drug Delivery and Cytotoxicity. Nikolova MP; Joshi PB; Chavali MS Pharmaceutics; 2023 Jun; 15(6):. PubMed ID: 37376098 [TBL] [Abstract][Full Text] [Related]
43. Toxicological Considerations, Toxicity Assessment, and Risk Management of Inhaled Nanoparticles. Bakand S; Hayes A Int J Mol Sci; 2016 Jun; 17(6):. PubMed ID: 27314324 [TBL] [Abstract][Full Text] [Related]
44. Advances in nanomedicine towards clinical application in oncology and immunology. Herreros E; Morales S; Cortés C; Cabaña M; Peñaloza JP; Jara L; Geraldo D; Otero C; Fernández-Ramires R Curr Pharm Biotechnol; 2014; 15(9):864-79. PubMed ID: 25213311 [TBL] [Abstract][Full Text] [Related]
45. Unique benefits of nanotechnology to drug delivery and diagnostics. McNeil SE Methods Mol Biol; 2011; 697():3-8. PubMed ID: 21116949 [TBL] [Abstract][Full Text] [Related]
46. Nanotoxicity: a challenge for future medicine. Akçan R; Aydogan HC; Yildirim MŞ; Taştekin B; Sağlam N Turk J Med Sci; 2020 Jun; 50(4):1180-1196. PubMed ID: 32283898 [TBL] [Abstract][Full Text] [Related]
52. Tumor-Acidity-Cleavable Maleic Acid Amide (TACMAA): A Powerful Tool for Designing Smart Nanoparticles To Overcome Delivery Barriers in Cancer Nanomedicine. Du JZ; Li HJ; Wang J Acc Chem Res; 2018 Nov; 51(11):2848-2856. PubMed ID: 30346728 [TBL] [Abstract][Full Text] [Related]
54. Nanoparticle-based toxicity in perishable vegetable crops: Molecular insights, impact on human health and mitigation strategies for sustainable cultivation. Sharma S; Shree B; Aditika ; Sharma A; Irfan M; Kumar P Environ Res; 2022 Sep; 212(Pt A):113168. PubMed ID: 35346658 [TBL] [Abstract][Full Text] [Related]
55. Nanotechnology Assisted Targeted Drug Delivery for Bone Disorders: Potentials and Clinical Perspectives. Zhao X; Li L; Chen M; Xu Y; Zhang S; Chen W; Liang W Curr Top Med Chem; 2020; 20(30):2801-2819. PubMed ID: 33076808 [TBL] [Abstract][Full Text] [Related]
56. Toxicity and efficacy of carbon nanotubes and graphene: the utility of carbon-based nanoparticles in nanomedicine. Zhang Y; Petibone D; Xu Y; Mahmood M; Karmakar A; Casciano D; Ali S; Biris AS Drug Metab Rev; 2014 May; 46(2):232-46. PubMed ID: 24506522 [TBL] [Abstract][Full Text] [Related]
57. Combinatorial Nano-Bio Interfaces. Cai P; Zhang X; Wang M; Wu YL; Chen X ACS Nano; 2018 Jun; 12(6):5078-5084. PubMed ID: 29883094 [TBL] [Abstract][Full Text] [Related]
58. Nanomaterials and nanoparticles: sources and toxicity. Buzea C; Pacheco II; Robbie K Biointerphases; 2007 Dec; 2(4):MR17-71. PubMed ID: 20419892 [TBL] [Abstract][Full Text] [Related]
59. Organoids: A new approach in toxicity testing of nanotherapeutics. Nabi SU; Ali SI; Rather MA; Sheikh WM; Altaf M; Singh H; Mumtaz PT; Mishra NC; Nazir SU; Bashir SM J Appl Toxicol; 2022 Jan; 42(1):52-72. PubMed ID: 34060108 [TBL] [Abstract][Full Text] [Related]